CJC-1295 (NO DAC) is an experimental GHRH (Growth Hormone Releasing Hormone) analogue peptide being studied in the laboratory for its role in stimulating the natural release of growth hormone (GH).
Primarily used in research to explore mechanisms related to energy metabolism, cellular recovery, and hormonal balance.
Composition
CJC-1295 (No. DAC) — 5 mg per vial (lyophilized form)
Experimental exhibition
• Quantities studied: 100–300 mcg in preclinical research
• Exploration of GH/IGF-1 signaling
• Analysis of cellular metabolic responses
• Studies conducted in controlled environments
Informative benefits
• Studied for stimulating GH release
• Research on muscle recovery
• Observation of energy metabolism
• Exploration of natural hormonal support
• Analysis of cell regeneration mechanisms
For research use only – Not intended for human consumption
